Skin structure improvement

Skin structure improvement" is not a canonical molecule, receptor, or recognized therapeutic target, but rather a general therapeutic goal referring to interventions that enhance the organization and function of skin tissue. It does not represent a unique protein, enzyme, receptor, or molecular entity. "Skin structure improvement" broadly refers to strategies, treatments, and biological mechanisms aimed at enhancing the composition and mechanical properties of the skin—such as increasing collagen content, improving elasticity, or promoting fibroblast activity—but it is not a specific molecular or pharmacological target. Scientific research on skin health and aging typically targets specific molecules or pathways (e.g., collagen type I, elastin, retinoic acid receptors, TGF-β signaling), but "skin structure improvement" is not itself a distinct target or measurable entity. If searching for relevant therapeutic targets, it is necessary to specify one or more molecular players (such as "collagen type I," "elastin," "retinoic acid receptor," or "fibroblast growth factor receptor") that contribute to skin structure and can be modulated for clinical benefit.